Trial Profile
A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Single and Multiple Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-490 Injection Administered Intravenously in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Plazomicin (Primary)
- Indications Bacteraemia; Gram-negative infections; Nosocomial infections; Pyelonephritis; Urinary tract infections
- Focus Adverse reactions
- Sponsors Achaogen
- 22 Jan 2019 Results of pooled analysis assessing the population pharmacokinetics for Plazomicin from 7 studies :NCT00822978, NCT01034774,NCT01462136,NCT01514929,NCT01096849,NCT01970371 and NCT02486627 were published in the Antimicrobial Agents and Chemotherapy
- 12 Sep 2011 Results published in Antimicrobial Agents and Chemotherapy.
- 09 Oct 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.